Patent · US Active

IL1-β Binding antibodies and fragments thereof

US7744865B2 · kind B2 · utility

11Cited by
21References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 11, 2009
Grant dateJun 29, 2010
Priority date
Expiry dateMay 11, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An IL-1β binding antibody or IL-1β binding fragment thereof comprising the amino acid sequence of SEQ ID NO: 8 and SEQ ID NO: 9, and related nucleic acids, vectors, cells, and compositions, as well as method of using same to treat or prevent a disease. IL-1β binding antibodies or IL-1β binding fragments thereof are provided which have desirable affinity and potency.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.